Cleared Traditional

K252164 - NorthStar™ Mapping System (FDA 510(k) Clearance)

Jan 2026
Decision
202d
Days
Class 2
Risk

K252164 is an FDA 510(k) clearance for the NorthStar™ Mapping System. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).

Submitted by Imricor Medical Systems (Burnsville, US). The FDA issued a Cleared decision on January 28, 2026, 202 days after receiving the submission on July 10, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.

Submission Details

510(k) Number K252164 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 10, 2025
Decision Date January 28, 2026
Days to Decision 202 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQK - Computer, Diagnostic, Programmable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1425

Similar Devices - DQK Computer, Diagnostic, Programmable

All 47
HemoSphere Nano Monitor (HSNANO1)
K253186 · Edwards Lifesciences, LLC · Feb 2026
CARTO™ 3 EP Navigation System V8.4
K252972 · Biosense Webster, Inc. · Feb 2026
IOPS Visionary System (MC-3)
K254089 · Centerline Biomedical, Inc. · Feb 2026
Holter ECG and ABP system (HolterABP)
K251591 · Edan Instruments, Inc. · Feb 2026
SafeBeat Rx App
K251218 · Safebeat Rx, Inc. · Feb 2026
CARTO™ 3 EP Navigation System V9.0 with PIU Plus
K254085 · Biosense Webster, Inc. · Jan 2026